Found 10 matching trials
Budesonide Application Via Mucosal Atomization Device as a Treatment for Chronic Rhinosinusitis When Utilized as a Topical Nasal Steroid Spray PHASE1 Budesonide, a steroid subtype, has been used as an adjunctive treatment for...
Show More Location
ENT Clinic, St. Paul's Hospital
Learn More & Join Trial
Comparison of Naloxone Pharmacokinetics PHASE1 Intranasal (IN) naloxone administration is an effective alternative to intr...
Show More Location
Vince and Associates Clinical Research
Learn More & Join Trial
The Optimal Head Position for Distributing Topical Nasal Medication Using the Mucosal Atomization Device PHASE4 Chronic Rhinosinusitis (CRS) is a common disorder of the nose characterized...
Show More Location
St. Paul's Hospital Sinus Centre
Learn More & Join Trial
A Usability Assessment of Naloxone by Community Members NA This will be a usability trial to assess administration of naloxone via int...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy of Budesonide Via Delayed Release vs Immediate Release EARLY_PHASE1 The aim of this study is to compare the efficacy of intranasal budesonide a...
Show More Location
Multiple Locations
Learn More & Join Trial
Prehospital Analgesia With Intra-Nasal Ketamine PHASE4 Acute painful conditions make-up a large proportion of pre-hospital transpo...
Show More Location
British Columbia Emergency Health Services Station 249
Learn More & Join Trial
CNS Uptake of Intranasal Glutathione PHASE1 Excessive free radical formation and depletion of the brain's primary antio...
Show More Location
University of Washington
Learn More & Join Trial
Phase IIb Study of Intranasal Glutathione in Parkinson's Disease PHASE2 Glutathione is an important nutrient for brain function and loss of glutath...
Show More Location
Bastyr University
Learn More & Join Trial
Comparing Budesonide Via MAD or INSI Prospective Cohort Study EARLY_PHASE1 Chronic Rhinosinusitis (CRS) is a common disorder in North America, affecti...
Show More Location
Multiple Locations
Learn More & Join Trial
Influenza Challenge Study to Determine the Optimal Infection Dose and Safety of a Recombinant H3N2 (A/Texas/71/2017 (H3N2, Clade 3C3a) Influenza Strain PHASE1 An open-label, dose-ranging influenza challenge study in healthy adult volu...
Show More Location
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
Learn More & Join Trial